期刊文献+

PLGA微球制备工艺对新城疫病毒稳定性的影响

Effects of formulation technique of PLGA microspheres on stability of Newcastle disease virus
下载PDF
导出
摘要 目的考察乳酸-羟乙醇酸共聚物(PLGA)微球制备工艺对新城疫病毒的稳定性影响,并寻求合适的保护剂以稳定新城疫病毒的活性。方法 采用复乳-溶剂挥发法制备PLGA微球,并添加不同的保护剂进行考察。紫外分光光度法测定蛋白浓度,利用红血球凝集反应测定病毒效价。结果涡旋、高速离心和搅拌等剪切力时新城疫病毒的活性影响不大;超声时病毒活性产生一定的影响;有机溶剂对病毒活性的影响最大;加保护剂可得到一定的改善。结论制备新城疫病毒的缓释PLGA微球时,宜加冰浴超声,或缩短超声时间,延长超声间隔;选用聚乙二醇6000或羟丙-β环糊精作保护剂可显著稳定病毒活性。如果可避免有机溶剂的使用,将极大地促进新城疫病毒的活性。 OBJECTIVE To evaluate the effects of fimnutation technique of PLGA microspheres on the stability of Newcastle disease virus and to look for a proper protectant to srdbilize Newcastle disease vinls. METHODS PI,GA mien)spheres with or without additives were prepared by a double-emulsinn solvent extraetion/evaloratinn method. The virus potency was detemlined by a hemagglutinin test. RESULTS The protein concentration was determined by UV speetrophotography. The sheafing forces, such as vortex, high speed centrifugation or stirring, had little influences on the activity of Newcastle disease virus. Meanwhile ultrasound had some effects, and organic solvents played the major key. The activity of virus was improved by adding some proteetants. CONCLUSION To prepare the better microsphers of PLGA, ultrasound should be performed in the iced bath, and the keeping time should be shorten and the interval time should be lengthen. Polyethylene glycol 6000 or HP-β-cyclodextrin was used as a protectant to stabilize the protein. The activity of Newcastle disease virus will be raised sharply if the organic solvents are avoided.
机构地区 浙江大学药学院
出处 《中国药学杂志》 EI CAS CSCD 北大核心 2005年第22期1724-1727,共4页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(30171113)
关键词 新城疫病毒 微球 乳酸-羟乙醇酸共聚物 稳定性 newcastle disease virus microsphems PIGA stability
  • 相关文献

参考文献10

  • 1刘开扬,刘芳.新城疫病毒抗癌作用及其应用的研究进展[J].中国肿瘤生物治疗杂志,2002,9(4):289-291. 被引量:2
  • 2古长庆,金宁一.鸡新城疫病毒抗肿瘤作用及其机制的研究进展[J].中国肿瘤生物治疗杂志,2000,7(3):238-239. 被引量:7
  • 3Phuangsab A, Lorence RM, Reichard KW, et al. Newcastle disease virus therapy of human tumor xenografts: Antitumor effects of local or systemic administration[J]. Cancer Lett ,2001,172( 1 ) :27.
  • 4Castellanos IJ, Cruz G, Crespo R, et al. Encapsulationinduced aggregation and loss in activity of γ-chymotrypsin and their prevention [J]. J Controlled Release, 2002,81:307.
  • 5Zheng CH, Liang WQ, Yu HY, et al. Evaluation of different methods to determine the loading of proteins in PLGA microspheres[J].Pharmazie ,2004,59 (3) :232.
  • 6van de Weert, Hoechstetter J, Hennink WE, et al. The effect of a water/organic solvent interface on the structural stability of lysozyme [J]. J Controlled Release, 2000,68 ( 3 ): 351.
  • 7Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals[J]. Int J Pharm, 1999,185(2): 129.
  • 8Kang J, Schwendeman SP. Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(d,llactidecglycolide) inplants[J]. Biomaterials ,2002,23(1) :239.
  • 9Diwan M, Park TG. Pegylation enhances protein stability stability during encapsulation in PLGA microspheres[J]. J Controlled Release,2001,73: 233.
  • 10Kang F, Jiang G, Hinderliter A, et al. Lysozyme stability in primary emulsion for PLGA microsphere preparation: effect of recovery methods and stabilizing excipients[ J ]. Pharm Res, 2002,19(5) :629.

二级参考文献22

  • 1白莲花,钱振超.新城鸡瘟病毒激活的巨噬细胞抗肿瘤转移作用的研究 [J].上海免疫学杂志,1994,14(6):334-336. 被引量:12
  • 2Reichard KW, Lorence RM, Cascino CJ. Newcastle disease virus selectively kills human tumor cells[ J]. Surg Res, 1992, 52 (5): 448-453.
  • 3Schirrmacher V, Haas C, Bonifer R, et al. Human tumor cell modification by virus infection: An efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus[ J]. Gene Ther 1999, 6 (1):63-73
  • 4Lorence RM, Reichard KW, Katubig BB, et al. Complete regres sion of human neuroblastoma xenografts in athyrnic mice after local Newcastle disease virus therapy[J]. J Natl CancerInst, 1994, 86 (16): 1228-133.
  • 5Phuangsab A, Lorence RM, Reichard KW, et al. Newcastle disease virus therapy of human tumor xenografts: Antitumor effects of local or systemic administration[ J ]. Cancer Lett, 2001,172 ( 1 ):27-36.
  • 6Schirrmacher V, Griesbach A, Ahlert T. Antitumor effects of Newcastle Disease Virus in vivo: Local versus systemic effects[J]. Int Oncol, 2001, 18(5): 945-952.
  • 7Schirrmacher V. in situ analysis of tumor-specific CTL effector and memory responses elicited by tumor vaccination [ J ]. Int Oncol, 1999, 15(2): 217-227 .
  • 8Termeer CC, Schirrmacher V, Brocker EB, et al. Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells[ J]. Cancer Gene Ther,2000, 7(2): 316-323.
  • 9Schirrmacher U, Bai L, Umansky V, et al. Newcastle virus activates macrophages for anti-tumor activity[ J]. Int J Oncol, 2000,16(2): 363-373.
  • 10Umansky V, Shatrov VA, Lehmann V. Induction of NO synthesis in macrophages by newcastle disease virus is associated with activation of nuclear factor kappa B[J]. Int Immunol, 1996, 8 (4):491-498.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部